Enterocele

2

Review clinical trials related to Enterocele. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Biological OviTex Versus Synthetic Graft in Robotic Prolapse Surgery

This prospective study aims to assess the efficacy of the OviTex 1S permanent mesh in pelvic floor surgery in comparison with the current standard polypropylene mesh.

Participants needed: 184
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Meander Medical CenterUpdated: Jan 2, 2026Locations: 1
Eligibility criteria

Indication for VMR or SCR set by the treating surgeon/gynecologist in accordance... [+4]

Mentally incompetent patients (unable to fulfil questionnaires). [+5]

Status: Recruiting

Multicenter Ventral Mesh Rectopexy Registry Collaborative

The goal of this multicenter observational study is to collect data prospectively of patients with pelvic organ prolapse undergoing ventral mesh rectopexy (as well as rectoceles, entero-/sigmoidoceles/ intussusception/ rectal prolapse or combined) by laparoscopy or robotic surgery and to evaluate the longterm functional outcomes. Secondly complications (mesh erosions, recurrence, reoperations) are evaluated. Following main questions will be analysed - other can follow in consultation with the collaborative 1. Is VMR the technique of choice for treatment of rectoceles? Functional results - recurrence - mesh related complications 2. Has a perineal descent an impact on the functional outcome of ventral mesh rectopexy perfored for external rectal prolaps, internal rectal prolaps, rectocele, enterocele, sigmoidcele or combined pelvic organ prolapse?

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, AntwerpUpdated: Oct 25, 2023Locations: 5Duration: 5 Years
Eligibility criteria

Diagnosis of posterior pelvic organ prolaps planned for laparoscopie or robotic... [+1]

Inability to complete a written informed conscent [+3]